• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global H1N1 vaccines market is currently exhibiting strong growth. The H1N1 virus, commonly known as swine flu is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the swine flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionaly, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.

IMARC Group’s latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines market in any manner.

Report Coverage:

  • Historical, Current and Future Market Trends
     
  • Breakup by Vaccine Type
    • Intramuscular
    • Intranasal
    • Intradermal
       
  • Breakup by Market Type:
    • Public
    • Private
       
  • Analysis of Key Brands:
    • Agripal
    • Fiuarix
    • Influgen
    • Influvac
    • Nasovac
    • Vaxigrip
    • Others
       
  • Breakup by Region:
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America
       

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global H1N1 vaccines industry?
  • What is the breakup of the market based on the vaccines type?
  • What is the breakup of the market based on the market type?
  • What are the various stages in the value chain of the global H1N1 vaccines industry?
  • What are the key driving factors and challenges in the global H1N1 vaccines industry?
  • What is the structure of the global H1N1 vaccines industry and who are the key players?
  • What is the degree of competition in the global H1N1 vaccines industry?
  • What are the profit margins in the global H1N1 vaccines industry?


1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global H1N1 Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Breakup by Vaccines Type 
    5.4    Breakup by Market Type
    5.5    Analysis of Key Brands
    5.6    Breakup by Region
    5.7    Market Forecast
6    Market Breakup by Vaccines Type
    6.1    Intramuscular
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Intranasal
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Intradermal
        6.3.1    Market Trends
        6.3.2    Market Forecast
7    Market Breakup by Type
    7.1    Public
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Private
        7.2.1    Market Trends
        7.2.2    Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Europe
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Asia Pacific
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Middle East and Africa
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Latin America
        8.5.1    Market Trends
        8.5.2    Market Forecast
9    Analysis Of Key Brand
    9.1    Agripal 
    9.2    Fiuarix 
    9.3    Influgen
    9.4    Influvac
    9.5    Nasovac 
    9.6    Vaxigrip 
    9.7    Others 
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
    13.1    Price Indicators
    13.2    Price Structure
    13.3    Margin Analysis
14    Industry Developments
    14.1    Pipeline and New Product Launches
    14.2    Mergers & acquisitions and Partnerships 
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players

List of Figures

Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2018
Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2018
Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2018
Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
Figure 8: Global: H1N1 Vaccines Industry: Porter’s Five Forces Analysis
Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2013-2018
Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2013-2018
Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2013-2018
Figure 15: Global: H1 N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2013-2018
Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2013-2018
Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2013-2018
Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2013-2018
Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2013-2018
Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2013-2018
Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2013-2018
Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024


List of Tables

Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2019-2024
Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2019-2024
Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 5: Global: H1N1 Vaccines Market Structure
Table 6: Global: H1N1 Vaccines Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links